Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Being able to generate large datasets has never been more important in biology given the potential of AI. Better synthesis technologies are essential. @fiftyyears company @tierrabio has $11m more to pioneer protein synthesis. More: https://t.co/V36RiWHRkK https://t.co/TYMAOqf9q6
We are delighted to announce our #investment in @TierraBio, the company behind the world’s first platform for producing proteins with predictive AI-guided cell-free technology. https://t.co/88aecd90BG #synbio #GenAI #funding #VC
.@tierrabio -a California-based startup developing AI-guided cell-free technology to enable high-throughput custom protein synthesis—has closed an $11.4m Series A round led by @materialimpact https://t.co/yw7nn8pKYX
Tierra Biosciences, a California-based startup, has secured $11.4 million in a Series A round led by Material Impact. The company is developing AI-guided cell-free technology to revolutionize protein synthesis, reducing manufacturing time from months to weeks. This investment aims to pioneer protein synthesis and leverage AI breakthroughs for genomic sequencing.
